Skip to primary navigation
Skip to main content
Skip to primary sidebar
Skip to footer
About
Contact Us
Search
Close Search Form
WeedWeek
WeedWeek is the best way to keep up with the green rush
Membership
My Account
LinkedIn
Instagram
Twitter
Politics
Money
Ops
Brands
Culture
Events
M&A & DEALS
Deloitte Hails Legalization 2.0—But Should We Trust Their Numbers?
IS THERE A MED GAP?
WEED DEALS GONE BAD ARE STILL A THING
GOOD LORD, WHAT HAVE Y’ALL DONE TO KRISTEN YODER?
“PEOPLE WE LOVE AND SUPPORT, THINK WE’RE EVIL”
SHOULDN’T THIS MAN HAVE THE ‘BURN BUD’ OPTION?
BILL PERMITTING PETS TO RECEIVE CANNABIS PASSES SENATE
WE SPENT SOME TIME WITH EUSTACE TILLEY… ON WEED!
NATION’S YOUNGEST REC STORE OWNER IS 20
PHARMACY DEBATE RAGES ON
HOME GROWING FEVER
LINTON: CANOPY CHOSE ACREAGE BECAUSE OF HEAVYWEIGHT BOARD’S “REPUTATIONAL RISK”
AURORA’S BRIGHT Q3 FINANCIALS
CANNABIS CONSUMPTION UP, BEER DOWN
AFTER DENVER, WHAT’S NEXT FOR HALLUCINOGENS?
HEMP PRODUCTION REGISTRATION HAS OPENED, AND THAT’S ABOUT ALL WE KNOW
AURORA PRIORITIZES HIGH-MARGIN MED, WON’T BET ON BEVS
CAN MEDMEN CONQUER THE MARKET?
CANOPY AGREES TO BUY ACREAGE FOR $3.4B, AFTER U.S. GOES REC
Previous Page
Page
1
Interim pages omitted
…
Page
24
Page
25
Page
26